IVPR · Inspire Veterinary Partners, Inc.
Market Cap
$752
Shares
3.76M
IVPR metrics
56 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$752
Price action
19 metricsPrice change (1W)
+100.0%
Price change (30D)
+100.0%
Price change (3M)
-88.2%
Price change (6M)
-92.0%
Price change (YTD)
-99.6%
Price change (1Y)
-100.0%
Trailing year
Price change (5Y)
—
52-week high
$1.11
52-week low
$0.00
Change from 52-week high
-100.0%
Change from 52-week low
+100.0%
Annualized volatility
411.8%
Beta
-0.5
RSI (14D)
42.8
Price vs SMA 50
-70.0%
Price vs SMA 200
-99.6%
Avg volume (3M)
1.22M
Relative volume
1.2
Average dollar volume
$1,331
Company
3 metricsSector
Consumer Cyclical
Industry
Personal Services
Shares outstanding
3.76M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 139.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 2,068,562.1%
P / book
0.0
reciprocal yield 554,188.3%
FCF yield
-577,089.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1,587,660.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 94.9%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 94.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
-52.2%
Trailing 12 months
Net margin
-76.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$8.13M
Net income (TTM)
−$11.94M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-27.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+6.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$15.56M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+225.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-286.5%
Return on assets
-49.9%
Debt / equity
2.8
Current ratio
0.4
EBITDA (TTM)
−$6.96M
Free cash flow (TTM)
−$4.34M
Quick ratio
0.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$11.18M
Latest balance sheet
Cash & equivalents
$576,246
Total assets
$23.96M
Total debt
$11.76M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$4.23M
Capital expenditures (TTM)
$108,143
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
0
13F filer change QoQ
-2
Institutional ownership
—
Short interest
3 metricsShort interest
35.5%
Latest settlement · 17.8 days to cover
Days to cover
17.8d
Short-squeeze score
67 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—